Compound Detail
CHEMBL5403964
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C)(C)NC(=O)C(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)C(F)(F)F)C1CCCCC1
Basic Information
| ChEMBL ID | CHEMBL5403964 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KEAASSFDBHSWDX-WLNPFYQQSA-N |
3
Targets
3
Activities
2
Assay Types
16
PK Parameters
4
Publications
0
Known Names
Molecular Properties
627.7
MW (Da)
1.74
ALogP
6
HBA
4
HBD
153.8
PSA (Ų)
0.29
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 7.28
IC50 1 meas. best 7.47
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Replicase polyprotein 1ab CHEMBL4523582 | IC50 | 7.47 | 7.47 | 34.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 7.28 | 7.28 | 53.0 | 1 |
| Human coronavirus OC43 CHEMBL5209665 | EC50 | 6.84 | 6.84 | 146.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 20714.43 | ng.hr.mL-1 | Mus musculus |
| AUC | 23476.35 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 212.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 25.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 33.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1023.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 42.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 17.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Mus musculus |
| CL | 2.55 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 4810.0 | nM | Mus musculus |
| Cmax | 3790.0 | nM | Rattus norvegicus |
| F | 32.0 | % | Mus musculus |
| F | 37.4 | % | Rattus norvegicus |
| T1/2 | 6.24 | hr | Mus musculus |
| T1/2 | 4.36 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Replicase polyprotein 1ab | IC50 | = | 34.0 | nM | 7.47 | Inhibition of SARS CoV-2 main protease preincubated for 30 min followed by subst... | 37182612 |
| SARS-CoV-2 | EC50 | = | 53.0 | nM | 7.28 | Antiviral activity against SARS-CoV-2 infected in human Vero cells assessed as r... | 37182612 |
| Human coronavirus OC43 | EC50 | = | 146.0 | nM | 6.84 | Antiviral activity against HCoV-OC43 infected in human MRC5 cells assessed as re... | 37182612 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37182612 | 10.1016/j.bmcl.2023.129324 | ADMET | 22 |
| 37182612 | 10.1016/j.bmcl.2023.129324 | Human coronavirus OC43 | 5 |
| 37182612 | 10.1016/j.bmcl.2023.129324 | Replicase polyprotein 1ab | 1 |
| 37182612 | 10.1016/j.bmcl.2023.129324 | SARS-CoV-2 | 1 |
Data from ChEMBL 36 via Core Engine